Related Experiment Videos
Torulopsis glabrata urinary tract infection treated with 5-fluorocytosine
Journal of Clinical Pathology
|January 1, 1974
Abstract:
Two diabetic patients with symptomatic urinary tract infection by Torulopsis glabrata were successfully treated with two-week courses of 5-fluorocytosine.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing.
The Journal of antimicrobial chemotherapy·2000
In-vitro activity of sanfetrinem against isolates of Streptococcus pneumoniae and Staphylococcus aureus.
The Journal of antimicrobial chemotherapy·1998
Serogroups/types and antibiotic resistance of referred isolates of Streptococcus pneumoniae: 1993 to 1995.
Communicable disease report. CDR review·1997
ALK overexpression without rearrangement widely exists in EWSR1/FUS-rearranged soft tissue tumours.
Journal of clinical pathology·2026
Adapt or Become Irrelevant: the Pathologist as the new Diagnostic Architect.
Journal of clinical pathology·2026
Targeted transcriptome profiling of oral cavity squamous cell carcinoma and histologic grade-associated gene expression patterns.
Journal of clinical pathology·2026
Serum versus lithium-heparin plasma for lipid testing: matrix-related bias and calculated LDL-C classification.
Journal of clinical pathology·2026
One syndrome, many diseases: toward precision pharmacotherapy in acute respiratory distress syndrome.
Frontiers in pharmacology·2026
Use of Sildenafil Citrate for the Treatment of Erectile Dysfunction in Stallions: First Case Reports.
Reproduction in domestic animals = Zuchthygiene·2026
Dupilumab for Drug-Induced Bullous Pemphigoid: A Case Series and Literature Review.
Clinical, cosmetic and investigational dermatology·2026
Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review.
Frontiers in pharmacology·2026
Opioid receptor agonist-antagonists in pain management: receptor specific mechanisms, dose response relationships, and clinical combination strategies.
Frontiers in pain research (Lausanne, Switzerland)·2026